Home - PM Group
Cell Gene Therapy (CGT) is a rapidly evolving field. PM Group has wide ranging expertise in the design and development of CGT facilities.
Adaptability of facilities
Adaptability is key in this fast-changing area of Advanced Therapeutic Medicinal Products (ATMPs). Adaptable facilities allow for faster speed to market for autologous and allogeneic cell therapies, gene therapies and associated vector and plasmid production. Flexible, adaptable facilities can also support a changing mix of modalities and evolving process technologies.
PM Group’s designs ensure speed, reliability and chain of identity throughout the facility and QC. We achieve this by integrating our architecture, process and advanced automation designs, ensuring a best in class solution.
Do you have a Cell Gene Therapy project? Talk to our experts.